Search clinical trials for: Angiogenin

Total 2117 results

TheraVitae Ltd.

Unknown

ACPs Combined With CABG in Patients With CHF

Congestive Heart Failure

Israel
UMC Utrecht
ZonMw: The Netherlands Organisation for Health Research and Development

Terminated

Management of Angiotensin Inhibitors During the Perioperative Period (AIPOP)

Surgery | Perioperative Complication | Angiotensin Hypertension

Netherlands, Canada
AHS Cancer Control Alberta

Completed

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

Glioma

Canada
University of Chile

Completed

Endothelial Damage and Angiogenesis Biomarkers During COVID-19

Covid19 | Endothelial Dysfunction | Angiogenesis | Cardiovascular Morbidity

Chile
Turkish Ophthalmology Society

Completed

The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease

Behçet's Disease

Turkey
TheraVitae Ltd.

Completed

ACPs in Severe PAD/CLI by Direct Intramuscular Injection

Peripheral Arterial Disease | Critical Limb Ischemia

Israel
TheraVitae Ltd.
Mahidol University

Unknown

EPC by Intracoronary Injection in Patients With Chronic Stable Angina

Coronary Artery Disease

Israel
Centre Hospitalier de PAU

Recruiting

Interrupters of VAscular daMAge in Malignant Hypertension (IVAMA)

Malignant Hypertension

France
University of Arizona
National Heart, Lung, and Blood Institute (NHLBI); Suburban Hospital

Suspended

Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG

Cognitive Impairment | Coronary Artery Bypass Surgery

United States
Sohag University

Not yet recruiting

Serum Levels of Angiotensin Converting Enzyme in Systemic Lupus Erythematous Patients

Systemic Lupus Erythematosus

Egypt
Children's Hospital Medical Center, Cincinnati

Completed

Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

Eosinophilic Esophagitis | Connective Tissue Disorders

United States
Chiang Mai University

Unknown

Effects of Renin-Angiotensin System Inhibitors in Peritoneal Dialysis Patients

Peritoneal Dialysis

Thailand
Shanghai Chest Hospital

Not yet recruiting

Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients

Cardiac Event | Immune Checkpoint Inhibitor | Adverse Reactions | Non-Small Cell Lung Cancer Patients
Nara Medical University

Completed

Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline

Hypertension | Brain Infarction

Japan
D'Or Institute for Research and Education
Brazilian Clinical Research Institute

Unknown

Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 (BRACE-CORONA)

COVID-19 | Corona Virus Infection

Brazil
Norwegian University of Science and Technology
AstraZeneca

Completed

Prophylactic Treatment of Episodic Cluster Headache

Cluster Headache

Norway
Soroka University Medical Center

Completed

Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy

Radiographic Contrast Agent Nephropathy
Unidad de Investigacion Medica en Enfermedades...

Completed

The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

Oxidative Stress

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...
National Council of Science and Technology, Mexico

Unknown

Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis

Atherosclerosis | Lupus Nephritis

Mexico
Massachusetts General Hospital

Completed

Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Development and Validation of the Prediction Model for Functional Mitral Regurgitation Regression in Heart Failure Patients Taking Guideline-directed Medical Therapy

Heart Failure | Mitral Regurgitation

China
Ottawa Heart Institute Research Corporation

Active, not recruiting

The COVID-RASi Trial (COVID-19)

Cardiovascular Diseases | COVID-19

Brazil, Canada, Mexico
University of California, San Francisco
Flight Attendant Medical Research Institute

Recruiting

Secondhand Tobacco Smoke and Cardiovascular Disease

Cardiovascular Diseases | Hypertension

United States
Medical University Innsbruck
Ludwig-Maximilians - University of Munich; Deutsches Zentrum für Herz-Kreislauf-Forschung...

Completed

Stopping ACE-inhibitors in COVID-19 (ACEI-COVID)

COVID-19 | SARS-CoV-2

Germany, Austria
Wonju Severance Christian Hospital

Recruiting

The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF (PARADE-HF)

Heart Failure | Mortality

Korea, Republic of
Medical Practice Prof D. Ivanov

Completed

ARB, ACEi, DRi Effects on COVID-19 Course Disease (BIRCOV)

COVID-19 | Hypertension

Ukraine
Brigham and Women's Hospital
Novartis

Terminated

Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan) (PARENT)

Congestive Heart Failure

United States
Pirogov Russian National Research Medical University

Completed

Impact of Treatment With VENARUS® on the Level of Monocyte Chemoattractant Protein 1 in Varicose Veins Blood

Varicose Veins

Russian Federation
Amy Arnold
American Heart Association

Recruiting

Angiotensin 1-7 in Obesity Hypertension

Hypertension | Obesity

United States
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Angiotensin-(1-7) Cardiovascular Effects in Aging

Aging

United States
Amy Arnold

Recruiting

Angiotensin-(1-7) and Energy Expenditure in Human Obesity

Obesity

United States
Maastricht University Medical Center

Completed

The Effect of Hesperidin on Glucose / Insulin Metabolism

Obesity | Metabolic Syndrome

Netherlands
Boehringer Ingelheim

Completed

Antihypertensive Medications and the Risk of Sepsis

Hypertension
Ain Shams University

Completed

The Effect of RAAS Blockers on ACE2 Levels

Renin-Angiotensin System

Egypt
Hakeam Abdulaziz Hakeam
King Khalid University Hospital; Princess Nourah Bint Abdulrahman University; Buraidah Central Hospital

Completed

Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives

COVID-19

Saudi Arabia
University of Arizona
United States Department of Defense

Not yet recruiting

Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury (ANGel T)

Traumatic Brain Injury
Emory University

Completed

A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers

Atrial Fibrillation | Atrial Flutter

United States
Institut universitaire de cardiologie et de pneumologie...
Odense University Hospital

Recruiting

Angiotensin Receptor Blockers in Aortic Stenosis (ARBAS)

Aortic Stenosis

Denmark, Canada
Rambam Health Care Campus
Constant Therapeutics LLC

Recruiting

Angiotensin 1-7 as a Therapy in the Treatment of COVID-19

COVID-19

Israel
US Biotest, Inc.
Tarix Pharmaceuticals

Terminated

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

HIV Infections

United States
Erasme University Hospital
Fonds Erasme pour la Recherche Medicale

Not yet recruiting

Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial (ATCO)

Respiratory Failure | SARS-CoV-2 | Coronavirus | Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere
Erasme University Hospital
Federal University of Minas Gerais; Fonds Erasme pour la Recherche Medicale; ...

Completed

Use of Angiotensin-(1-7) in COVID-19

Respiratory Failure | Infection, Coronavirus

Brazil
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function

Myocardial Infarction | Hypertension | Atherosclerosis | Heart Failure, Congestive

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

Myocardial Infarction | Hypertension | Atherosclerosis | Heart Failure, Congestive

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Withdrawn

Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

Hyperoxaluria
Tarix Pharmaceuticals
Constant Therapeutics LLC

Terminated

Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients (TXA127-PBSC)

Lymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin Disease

United States
Shiga University

Completed

Shiga Microalbuminuria Reduction Trial-2

Hypertension | Type 2 Diabetes Mellitus

Japan
University of Alabama at Birmingham

Completed

The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study (FAACET)

Proteinuria | Fabry Disease

United States, Slovenia
Stanford University

Withdrawn

Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients

Covid19

United States
University of Arizona

Suspended

Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients

Cognitive Impairment | Chronic Heart Failure

United States

Search clinical trials for: Angiogenin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations